CF PHARMTECH (02652) spent HK$421,300 to repurchase 12,000 shares on January 27th.
Changfeng Medicine (02652) announced that on January 27, 2026, it spent HKD 42.13 thousand to repurchase 12,000 shares.
CF PHARMTECH (02652) announced that it will spend HK$421,300 to repurchase 12,000 shares on January 27, 2026.
Related Articles
GigaDevice Semiconductor Inc. (03986) will fully exercise the oversubscribed rights issue, stabilize prices and end the stabilization period.
DYNAGREEN ENV(01330): "Green Dynamic Convertible Bond" will pay interest on February 25th.
LAUNCH TECH (02488): China Securities Regulatory Commission issues a filing notice for the company's H-share full circulation application.
GigaDevice Semiconductor Inc. (03986) will fully exercise the oversubscribed rights issue, stabilize prices and end the stabilization period.
DYNAGREEN ENV(01330): "Green Dynamic Convertible Bond" will pay interest on February 25th.
LAUNCH TECH (02488): China Securities Regulatory Commission issues a filing notice for the company's H-share full circulation application.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
